{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:23:36Z","timestamp":1787840616794,"version":"build-2784847793"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Submacular hemorrhage (SMH) causes irreversible loss of vision as it causes permanent anatomical and functional damage to photoreceptors. The various causes include polypoidal choroidal vasculopathy, neovascular age-related macular degeneration, retinal artery macroaneurysm, high myopia, and trauma. The current treatment modalities include antivascular endothelial growth factor (anti-VEGF) monotherapy, anti-VEGF \u00b1 gas pneumatic displacement \u00b1 intravitreal recombinant tissue plasminogen activator injection (rtPA), and triple therapy (intravitreal anti-VEGF + intravitreal rtPA + perfluoropropane gas injection). The surgical displacement of the SMH by vitrectomy with subretinal tissue plasminogen activator injection + intravitreal anti-VEGF + gas tamponade has been a valuable addition to our armamentarium. Evidence suggests that this novel technique provides better anatomical and functional outcomes in terms of visual acuity when the surgical displacement is performed within the prompt time frame in comparison to other available modalities of treatment. The current lacuna in the literature is the absence of level 1 evidence to support the surgical displacement as the first-line therapy. Hence, we review the current evidence and provide recommendations regarding this ever-promising therapy that can be vision-saving.<\/jats:p>","DOI":"10.4103\/ojo.ojo_98_25","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:02:00Z","timestamp":1761670920000},"page":"284-290","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Subretinal injection of tissue plasminogen activator for submacular hemorrhage \u2013 When and how to do"],"prefix":"10.4103","volume":"18","author":[{"given":"R.","family":"Sriram","sequence":"first","affiliation":[{"name":"Department of Vitreo-Retinal Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George J.","family":"Manayath","sequence":"additional","affiliation":[{"name":"Department of Vitreo-Retinal Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"R1-20251030","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ajo.2015.01.024","article-title":"Anti-vascular endothelial growth factor with or without pneumatic displacement for submacular hemorrhage","volume":"159","author":"Shin","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R2-20251030","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1167\/iovs.14-15838","article-title":"Inner segment remodeling and mitochondrial translocation in cone photoreceptors in age-related macular degeneration with outer retinal tubulation","volume":"56","author":"Litts","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-20251030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000027400","article-title":"Natural history of macular subretinal hemorrhage in age-related macular degeneration","volume":"213","author":"Scupola","year":"1999","journal-title":"Ophthalmologica"},{"key":"R4-20251030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/jcm12031035","article-title":"Efficacy evaluation of tissue plasminogen activator with anti-vascular endothelial growth factor drugs for submacular hemorrhage treatment:A meta-analysis","volume":"12","author":"He","year":"2023","journal-title":"J Clin Med"},{"key":"R5-20251030","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/bjo.2005.085001","article-title":"Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator","volume":"90","author":"Singh","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R6-20251030","doi-asserted-by":"crossref","first-page":"e1569","DOI":"10.1111\/aos.15137","article-title":"Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice:Data from the FRB!registry","volume":"100","author":"Gabrielle","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"R7-20251030","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000380830","article-title":"Identification of underlying causes of spontaneous submacular hemorrhage by indocyanine green angiography","volume":"233","author":"Kim","year":"2015","journal-title":"Ophthalmologica"},{"key":"R8-20251030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2016.06.014","article-title":"Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal vasculopathy","volume":"169","author":"Cho","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"R9-20251030","doi-asserted-by":"crossref","first-page":"e706","DOI":"10.1111\/aos.14676","article-title":"Massive submacular haemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular degeneration","volume":"99","author":"Cho","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"R10-20251030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/IAE.0000000000003294","article-title":"AStep-wise approach to the management of submacular haemorrhage using pneumatic displacement and vitrectomy;the Manchester protocol","volume":"42","author":"Chew","year":"2022","journal-title":"Retina"},{"key":"R11-20251030","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9394(99)00239-1","article-title":"A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits","volume":"128","author":"Kamei","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R12-20251030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00006982-200003000-00005","article-title":"Intravitreal injection of tissue plas- minogen activator and gas in subretinal hemorrhage caused by age-related macular degeneration","volume":"20","author":"Krepler","year":"2000","journal-title":"Retina"},{"key":"R13-20251030","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1097\/IAE.0b013e318287d99d","article-title":"Comparison of pneumatic displacement for sub- macular hemorrhages with gas alone and gas plus tissue plasminogen activator","volume":"33","author":"Fujikawa","year":"2013","journal-title":"Retina"},{"key":"R14-20251030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00417-009-1158-7","article-title":"Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator","volume":"248","author":"Hillenkamp","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R15-20251030","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/jamaophthalmol.2013.5464","article-title":"Subretinal pneumatic displacement of subretinal hemorrhage","volume":"131","author":"Martel","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R16-20251030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0002-9394(00)00575-4","article-title":"Perifoveal microcirculation before and after vitrectomy for diabetic cystoid macular edema","volume":"130","author":"Kadonosono","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R17-20251030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/APO.0000000000000130","article-title":"Modified approach in management of submacular hemorrhage secondary to wet age-related macular degeneration","volume":"5","author":"Kumar","year":"2016","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"R18-20251030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.oret.2017.07.012","article-title":"Pneumatic displacement of submacular hemorrhage with subretinal air and tissue plasminogen activator:Initial United States Experience","volume":"2","author":"Sharma","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R19-20251030","first-page":"3663","article-title":"Subretinal pneumatic displacement without tissue plasminogen activator for submacular hemorrhage:One-year outcomes","volume":"62","author":"Marwan","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-20251030","first-page":"3160963","article-title":"Visual outcome after vitrectomy with subretinal tPA injection to treat submacular hemorrhage secondary to age-related macular degeneration or macroaneurysm","volume":"2021","author":"Ali","year":"2021","journal-title":"J Ophthalmol"},{"key":"R21-20251030","first-page":"5792","article-title":"Outcomes of subretinal high-dose tissue plasminogen activator injection in massive submacular hemorrhage","volume":"60","author":"Peter","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-20251030","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0002-9394(00)00734-0","article-title":"Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration","volume":"131","author":"Haupert","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"R23-20251030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s12886-024-03660-x","article-title":"Combined treatment of submacular hemorrhage with low-dose subretinal recombinant tissue plasminogen activator and intravitreal conbercept","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"R24-20251030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13063-021-05966-3","article-title":"Vitrectomy, subretinal tissue plasminogen activator and intravitreal gas for submacular haemorrhage secondary to exudative age-related macular degeneration (TIGER):Study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial","volume":"23","author":"Jackson","year":"2022","journal-title":"Trials"},{"key":"R25-20251030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000537953","article-title":"Displacement of submacular hemorrhage using subretinal cocktail injection versus pneumatic displacement:A real-world comparative study","volume":"247","author":"Szeto","year":"2024","journal-title":"Ophthalmologica"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_98_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:25:57Z","timestamp":1787837157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_98_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_98_25","relation":{},"ISSN":["0974-620X","0974-7842"],"issn-type":[{"value":"0974-620X","type":"print"},{"value":"0974-7842","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-03-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}